- Home
- GAME vs TPST Comparison
GAME vs TPST Comparison
Compare GAME & TPST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GAME
- TPST
- Stock Information
- Founded
- GAME 2011
- TPST 2011
- Country
- GAME United States
- TPST United States
- Employees
- GAME N/A
- TPST N/A
- Industry
- GAME
- TPST Biotechnology: Pharmaceutical Preparations
- Sector
- GAME
- TPST Health Care
- Exchange
- GAME Nasdaq
- TPST Nasdaq
- Market Cap
- GAME 23.2M
- TPST 27.2M
- IPO Year
- GAME 2009
- TPST N/A
- Fundamental
- Price
- GAME $0.85
- TPST $0.78
- Analyst Decision
- GAME Strong Buy
- TPST Strong Buy
- Analyst Count
- GAME 3
- TPST 4
- Target Price
- GAME $3.67
- TPST $20.00
- AVG Volume (30 Days)
- GAME 173.6K
- TPST 1.5M
- Earning Date
- GAME 11-14-2024
- TPST 11-12-2024
- Dividend Yield
- GAME N/A
- TPST N/A
- EPS Growth
- GAME N/A
- TPST N/A
- EPS
- GAME N/A
- TPST N/A
- Revenue
- GAME $99,072,646.00
- TPST N/A
- Revenue This Year
- GAME $102.07
- TPST N/A
- Revenue Next Year
- GAME $17.85
- TPST N/A
- P/E Ratio
- GAME N/A
- TPST N/A
- Revenue Growth
- GAME 210.51
- TPST N/A
- 52 Week Low
- GAME $0.65
- TPST $0.70
- 52 Week High
- GAME $2.25
- TPST $6.00
- Technical
- Relative Strength Index (RSI)
- GAME 41.28
- TPST 27.47
- Support Level
- GAME $0.76
- TPST $0.86
- Resistance Level
- GAME $0.95
- TPST $0.83
- Average True Range (ATR)
- GAME 0.08
- TPST 0.07
- MACD
- GAME -0.02
- TPST -0.01
- Stochastic Oscillator
- GAME 10.28
- TPST 4.33
About GAME GameSquare Holdings Inc.
GameSquare Holdings Inc is a vertically integrated, digital media, entertainment and technology company that connects brands with gaming and youth culture audiences. The company's end-to-end platform includes Gaming Community Network (a "GCN"), a digital media company focused on gaming and esports audiences, Swingman LLC dba as Zoned, a gaming and lifestyle marketing agency, and Code Red Esports Ltd. The company's geographical segment includes the United Kingdom, the USA, and Spain. The company generates the majority of its revenue from the USA. The company's sources of revenue consist of Teams, Agency, and SaaS + Advertising.
About TPST Tempest Therapeutics Inc.
Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.